PRME News and Press, First Trust Heitman Global Prime Real Estate ETF

2026-03-06 17:25:54 ET Prime Medicine, Inc. (PRME) TD Cowen 46th Annual Health Care Conference March 4, 2026 1:10 PM EST... Read the full article on Seeking Alpha For further details see: Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Tra...

2026-03-03 15:38:43 ET More on Prime Medicine Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond Prime Medicine slips after Q4 updates ...

2026-03-03 13:22:14 ET More on Prime Medicine Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond Seeking Alpha’s Quant Rating on Prim...

-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment -- -- Prime Medicine reported cas...

Sunstone Hotel Investors Inc. (SHO) is expected to report $0.18 for Q4 2025 GT Biopharma Inc. (GTBP) is expected to report $-0.22 for Q4 2025 Global Partners LP representing Limited Partner Interests (GLP) is expected to report $0.6 for Q4 2025 4D Molecular Therapeutics Inc. (FDMT) is...

CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in three upcoming conferences: T...

2026-01-28 08:05:23 ET Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine DENVER, Colo – CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine ...

2026-01-14 14:16:05 ET Prime Medicine, Inc. (PRME) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Confer...

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Allan Reine, M.D., Chief Executive Officer of Prime Medicine, will prese...

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize Canada NewsWire Issued on behalf of Avant Technologies Inc. VANCOUVER, BC , Jan. 2, 2026 /CNW/ -- Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032,...